Meclizine Hydrochloride Tablets, USP 12.5 mg
Recalled by Amerisource Health Services LLC
![Product image for Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=af1e45ca-1478-4eeb-8fdc-4f3d3eda4ed5&name=12.5+mg+Meclizine+Hydrochloride+Tablet+Blister.jpg.jpg)
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Amerisource Health Services LLC has recalled Meclizine Hydrochloride Tablets, USP 12.5 mg, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on April 1, 2026 and was initiated on March 16, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Meclizine Hydrochloride Tablets, USP 12.5 mg, with approximately 697 cartons affected. The company behind the recall is Amerisource Health Services LLC, based in Columbus, OH. The FDA describes the product as: “Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.”
Why was Meclizine Hydrochloride Tablets, USP 12.5 mg recalled?
According to the FDA, the stated reason for the recall is: “Failed tablet specifications.”
What should you do?
If you think you may have bought Meclizine Hydrochloride Tablets, USP 12.5 mg, compare it against the product description and identifying codes (Lot #1024852; Exp 9/30/2026) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Amerisource Health Services LLC or your local health authority.
About this recall
This recall was distributed in OH. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- April 1, 2026
- Recall started
- March 16, 2026
- Distributed in
- OH
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Meclizine Hydrochloride Tablets, USP 12.5 mg recalled?+
According to the FDA: Failed tablet specifications.
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Meclizine Hydrochloride Tablets, USP 12.5 mg?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0418-2026. Information last synced from the FDA on July 5, 2026.